193 related articles for article (PubMed ID: 25977922)
1. Anti-Lung Cancer Activity of the Curcumin Analog JZ534 In Vitro.
Wu J; Cai Z; Wei X; Chen M; Ying S; Shi L; Xu RA; He F; Liang G; Zhang X
Biomed Res Int; 2015; 2015():504529. PubMed ID: 25977922
[TBL] [Abstract][Full Text] [Related]
2. In-silico and in-vitro anti-cancer potential of a curcumin analogue (1E, 6E)-1, 7-di (1H-indol-3-yl) hepta-1, 6-diene-3, 5-dione.
Sufi SA; Adigopula LN; Syed SB; Mukherjee V; Coumar MS; Rao HS; Rajagopalan R
Biomed Pharmacother; 2017 Jan; 85():389-398. PubMed ID: 27889234
[TBL] [Abstract][Full Text] [Related]
3. Curcumin analogue A501 induces G2/M arrest and apoptosis in non-small cell lung cancer cells.
Xia YQ; Wei XY; Li WL; Kanchana K; Xu CC; Chen DH; Chou PH; Jin R; Wu JZ; Liang G
Asian Pac J Cancer Prev; 2014; 15(16):6893-8. PubMed ID: 25169542
[TBL] [Abstract][Full Text] [Related]
4. Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade- and mitochondria-dependent pathways.
Wu SH; Hang LW; Yang JS; Chen HY; Lin HY; Chiang JH; Lu CC; Yang JL; Lai TY; Ko YC; Chung JG
Anticancer Res; 2010 Jun; 30(6):2125-33. PubMed ID: 20651361
[TBL] [Abstract][Full Text] [Related]
5. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition.
Selvendiran K; Ahmed S; Dayton A; Kuppusamy ML; Rivera BK; Kálai T; Hideg K; Kuppusamy P
Cancer Biol Ther; 2011 Nov; 12(9):837-45. PubMed ID: 21885917
[TBL] [Abstract][Full Text] [Related]
6. A Soft Coral-Derived Compound, 11-Dehydrosinulariolide, Induces G2/M Cell Cycle Arrest and Apoptosis in Small Cell Lung Cancer.
Lin YC; Su JH; Lin SC; Chang CC; Hsia TC; Tung YT; Lin CC
Mar Drugs; 2018 Nov; 16(12):. PubMed ID: 30513611
[TBL] [Abstract][Full Text] [Related]
7. Hexamethoxylated Monocarbonyl Analogues of Curcumin Cause G2/M Cell Cycle Arrest in NCI-H460 Cells via Michael Acceptor-Dependent Redox Intervention.
Li Y; Zhang LP; Dai F; Yan WJ; Wang HB; Tu ZS; Zhou B
J Agric Food Chem; 2015 Sep; 63(35):7731-42. PubMed ID: 26255837
[TBL] [Abstract][Full Text] [Related]
8. DAT-230, a novel microtubule inhibitor, exhibits potent anti-tumor activity by inducing G2/M phase arrest, apoptosis in vitro and perfusion decrease in vivo to HT-1080.
Qiao F; Zuo D; Shen X; Qi H; Wang H; Zhang W; Wu Y
Cancer Chemother Pharmacol; 2012 Aug; 70(2):259-70. PubMed ID: 22752214
[TBL] [Abstract][Full Text] [Related]
9. SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivo.
Xia Y; Lei Q; Zhu Y; Ye T; Wang N; Li G; Shi X; Liu Y; Shao B; Yin T; Zhao L; Wu W; Song X; Xiong Y; Wei Y; Yu L
Cancer Lett; 2014 Dec; 355(2):297-309. PubMed ID: 25301449
[TBL] [Abstract][Full Text] [Related]
10. RL71, a second-generation curcumin analog, induces apoptosis and downregulates Akt in ER-negative breast cancer cells.
Yadav B; Taurin S; Larsen L; Rosengren RJ
Int J Oncol; 2012 Sep; 41(3):1119-27. PubMed ID: 22710975
[TBL] [Abstract][Full Text] [Related]
11. A new curcumin analogue exhibits enhanced antitumor activity in nasopharyngeal carcinoma.
Pan Y; Xiao J; Liang G; Wang M; Wang D; Wang S; Yang H
Oncol Rep; 2013 Jul; 30(1):239-45. PubMed ID: 23673810
[TBL] [Abstract][Full Text] [Related]
12. Curcumin analog WZ35 induced cell death via ROS-dependent ER stress and G2/M cell cycle arrest in human prostate cancer cells.
Zhang X; Chen M; Zou P; Kanchana K; Weng Q; Chen W; Zhong P; Ji J; Zhou H; He L; Liang G
BMC Cancer; 2015 Nov; 15():866. PubMed ID: 26546056
[TBL] [Abstract][Full Text] [Related]
13. Curcumin analog L48H37 induces apoptosis through ROS-mediated endoplasmic reticulum stress and STAT3 pathways in human lung cancer cells.
Feng C; Xia Y; Zou P; Shen M; Hu J; Ying S; Pan J; Liu Z; Dai X; Zhuge W; Liang G; Ruan Y
Mol Carcinog; 2017 Jul; 56(7):1765-1777. PubMed ID: 28218464
[TBL] [Abstract][Full Text] [Related]
14. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells.
Shin DY; Sung Kang H; Kim GY; Kim WJ; Yoo YH; Choi YH
Biomed Pharmacother; 2013 May; 67(4):305-11. PubMed ID: 23582784
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of Cyclin B1 mediates nagilactone E-induced G2 phase cell cycle arrest in non-small cell lung cancer cells.
Zhang LL; Feng ZL; Su MX; Jiang XM; Chen X; Wang Y; Li A; Lin LG; Lu JJ
Eur J Pharmacol; 2018 Jul; 830():17-25. PubMed ID: 29680228
[TBL] [Abstract][Full Text] [Related]
16. Curcumin enhances the anti-cancer effects of Paris Saponin II in lung cancer cells.
Man S; Zhang L; Cui J; Yang L; Ma L; Gao W
Cell Prolif; 2018 Aug; 51(4):e12458. PubMed ID: 29608021
[TBL] [Abstract][Full Text] [Related]
17. Licochalcone A Inhibits the Proliferation of Human Lung Cancer Cell Lines A549 and H460 by Inducing G2/M Cell Cycle Arrest and ER Stress.
Qiu C; Zhang T; Zhang W; Zhou L; Yu B; Wang W; Yang Z; Liu Z; Zou P; Liang G
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28805696
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative effect of an analog of curcumin bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione in human breast cancer cells.
Kumaravel M; Sankar P; Rukkumani R
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1900-7. PubMed ID: 23242714
[TBL] [Abstract][Full Text] [Related]
19. Curcumin improves the antitumor effect of X-ray irradiation by blocking the NF-κB pathway: an in-vitro study of lymphoma.
Qiao Q; Jiang Y; Li G
Anticancer Drugs; 2012 Jul; 23(6):597-605. PubMed ID: 22273827
[TBL] [Abstract][Full Text] [Related]
20. RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER‑negative breast cancer models.
Yadav B; Taurin S; Larsen L; Rosengren RJ
Int J Oncol; 2012 Nov; 41(5):1723-32. PubMed ID: 22971638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]